DeSci (Decentralized Science) is becoming a hot topic in the blockchain industry, sparking widespread discussion, especially in the field of innovative drug funding. However, there is a significant mismatch between DeSci and the biopharmaceutical industry in terms of funding, timelines, and operational models, making integration highly challenging. This article provides an in-depth analysis of the current state, challenges, and potential development paths of DeSci in the innovative drug sector, including new models such as IP-NFTs, RWAs, and clinical data prediction.
2/14/2025, 10:32:05 AM